Although only few donors exhibited enough EBV-specific CD8+ T cells to conduct the assay, CLL-derived EBV-specific CD8+ T cells showed a significantly decreased ability to induce target cell death compared to HC (Fig. 1G). Here, CD8A is linked to B-cell chronic lymphocytic leukemia.